Quince Therapeutics logo

Quince Therapeutics Funding & Investors

Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the site of bone diseases to promote more rapid healing with fewer off-target safety concerns. Quince Therapeutics serves customers in the United States.

https://www.quincetx.com/

Total Amount Raised: $225,000,000

Quince Therapeutics Funding Rounds

  • Post Ipo Equity

    $125,000,000

    Post Ipo Equity Investors

    KG Investments
  • IPO

    Unknown

  • Series B

    $76,000,000

    Series B Investors

    Sequoia Capital
    Pfizer Venture Investments
    Verily Life Sciences
    Lamond Family
    Dolby Family Ventures
    Huizenga Capital Management
    Breakout Ventures
    Takeda Ventures
    Vulcan Capital
    EPIQ Capital Group
    SMALLCAP World Fund
    RS Investments
  • Debt Financing

    $8,000,000

    Debt Financing Investors

    Breakout Ventures
    Takeda Ventures
    Pfizer
    Dolby Family Ventures
    Lamond Family
  • Series A

    $15,000,000

    Series A Investors

    Pfizer
    Takeda Ventures
    Dolby Family Ventures
  • Seed

    $1,000,000

    Seed Investors

    Dolby Family Ventures
Funding info provided by Diffbot.